Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
June 14, 2018
Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic
Joseph A Reddy, Ryan Dorton, Alicia Bloomfield, et al.
Cancer Research
|
May 8, 2007
Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate
Joseph A Reddy, Ryan Dorton, Elaine Westrick, et al.
The Journal of Organic Chemistry
|
July 3, 2007
An assembly concept for the consecutive introduction of unsymmetrical disulfide bonds: synthesis of a releasable multidrug conjugate of folic acid
Iontcho R Vlahov, Hari Krishna R Santhapuram, Yu Wang, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2017
Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy
Christopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
Molecular Pharmaceutics
|
July 28, 2009
In vivo structural activity and optimization studies of folate-tubulysin conjugates
Joseph A Reddy, Ryan Dorton, Alicia Dawson, et al.
Cancer Research
|
July 10, 2007
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate
Joseph A Reddy, Elaine Westrick, Hari K R Santhapuram, et al.
Bioconjugate Chemistry
|
February 26, 2014
Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship
Christopher P Leamon, Iontcho R Vlahov, Joseph A Reddy, et al.
Molecular Pharmaceutics
|
July 30, 2019
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys
Haiyan Chu, Jonathan M Shillingford, Joseph A Reddy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 28, 2010
Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications
Christopher P Leamon, Joseph A Reddy, Patrick J Klein, et al.
Bioconjugate Chemistry
|
December 7, 2017
Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates
Iontcho R Vlahov, Longwu Qi, Paul J Kleindl, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
June 14, 2018
Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic
Joseph A Reddy, Ryan Dorton, Alicia Bloomfield, et al.
Cancer Research
|
May 8, 2007
Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate
Joseph A Reddy, Ryan Dorton, Elaine Westrick, et al.
The Journal of Organic Chemistry
|
July 3, 2007
An assembly concept for the consecutive introduction of unsymmetrical disulfide bonds: synthesis of a releasable multidrug conjugate of folic acid
Iontcho R Vlahov, Hari Krishna R Santhapuram, Yu Wang, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2017
Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy
Christopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
Molecular Pharmaceutics
|
July 28, 2009
In vivo structural activity and optimization studies of folate-tubulysin conjugates
Joseph A Reddy, Ryan Dorton, Alicia Dawson, et al.
Cancer Research
|
July 10, 2007
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate
Joseph A Reddy, Elaine Westrick, Hari K R Santhapuram, et al.
Bioconjugate Chemistry
|
February 26, 2014
Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship
Christopher P Leamon, Iontcho R Vlahov, Joseph A Reddy, et al.
Molecular Pharmaceutics
|
July 30, 2019
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys
Haiyan Chu, Jonathan M Shillingford, Joseph A Reddy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 28, 2010
Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications
Christopher P Leamon, Joseph A Reddy, Patrick J Klein, et al.
Bioconjugate Chemistry
|
December 7, 2017
Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates
Iontcho R Vlahov, Longwu Qi, Paul J Kleindl, et al.
Page
of 4